Research subject advocates: To whom are they loyal?

Clinical and Investigative Medicine

Volumn 26, Issue 2, 2003, Pages 64-69

  Bramstedt, Katrina A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; GOVERNMENT; HEALTH CARE PERSONNEL; HUMAN; LAW; MEDICAL EDUCATION; MEDICAL ETHICS; MEDLINE; NURSE; PRIORITY JOURNAL; REVIEW; TASK PERFORMANCE; UNITED STATES; WORKMAN COMPENSATION;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; ETHICS, RESEARCH; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; INTERPROFESSIONAL RELATIONS; PATIENT ADVOCACY; RESEARCH SUBJECTS; VULNERABLE POPULATIONS;

EID: 0037662965     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Rockwell DH, Yobs AR, Moore MB. The Tuskegee study of untreated syphilis: the 30th year of observation. Arch Intern Med 1964;144:792-8.
2. Annas G, Grodin M, editors. The Nazi doctors and the Nuremberg code. Oxford: Oxford University Press; 1992.
3. Code of Federal Regulations. Title 45, public welfare. Pt. 46, protection of human subjects. Available http://ohrp.osophs.dhhs.gov/humansubjects/guidance/45cfr46.htm (accessed 2003 Mar 20).
4. National Institutes of Health. Required education in the protection of human research participants. Bethesda (MD): National Institutes of Health; 2000 Jun 5. Available: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html (accessed 2003 Mar. 17).
5. Pizzi LT, Goldfarb NI, Nash DB. Procedures for obtaining informed consent. In: Markowitz AJ, Wachter RM, editors. Making health care safer: a critical analysis of patient safety practices. Rockville (MD): Agency for Healthcare Research and Quality; 2001.
6. National Institutes of Health. Guidelines for general clinical research centers program (MO1). Bethesda (MD): National Institutes of Health; 2001 Nov. Available: www.ncrr.nih.gov/clinical/crguide2001/guidenov2001.pdf (accessed 2003 Mar 21).
7. Simmons PD. Ethical considerations in composite tissue allotransplantation. Microsurgery 2000;20:458-65.
8. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987;17(2):20-4.
9. Riecken HW, Ravich R. Informed consent to biomedical research in Veterans Administration Hospitals. JAMA 1982;248:344-8.
10. Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA 1982;248:968-70.
11. Tufts Center for the Study of Drug Development. Tufts Center for the Study of Drug Development pegs costs of a new prescription medicine at $802 million [news release]. Boston: Tufts Center for the Study of Drug Development; 2001 Nov 30. Available: http://csdd.tufts.edu/newsevents/recentnews.asp?newsi d=6 (accessed 2003 Mar. 17).
12. Rothstein MA, Anderlik MR. The AbioCor artificial replacement heart: bioengineering meets bioethics. J Cardiothorac Vasc Anesth 2002;16:234-9.
13. Cooke R. Advocates speak for the severely ill. Los Angeles Times 2001 July 23; sect S:1.
14. DeVries WC. The physician, the media, and the 'spectacular' case. JAMA 1988;259:886-90.
15. Fins JJ, Miller FG. Enrolling decisionally incapacitated subjects in neuropsychiatric research. CNS Spectr 2000;5:32-42.
16. Adshead G. Informed consent and psychiatric research [review]. Ann Ist Super Sanita 1997;33:497-503.